Stay updated with breaking news from Michaelk Handley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FORT COLLINS, CO / ACCESSWIRE / January 24, 2023 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that
Statera Biopharma has announced its intent to enter into a non-binding term sheet with regard to a strategic partnership with Lay Sciences.
FORT COLLINS, Colo., May 13, 2022 -- Statera Biopharma , a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today...
FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis,
Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease - read this article along with other careers information, tips and advice on BioSpace